0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Rapid Virus Diagnostic Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-3H8192
Home | Market Reports | Computers & Electronics| Software
Global Rapid Virus Diagnostic Test Market Insights and Forecast to 2028
BUY CHAPTERS

Rapid Virus Diagnostic Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-3H8192
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rapid Virus Diagnostic Test - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rapid Virus Diagnostic Test - Market

Rapid Virus Diagnostic Test - Market

The global market for Rapid Virus Diagnostic Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rapid Virus Diagnostic Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rapid Virus Diagnostic Test by region & country, by Type, and by Application.
The Rapid Virus Diagnostic Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Virus Diagnostic Test.
Market Segmentation

Scope of Rapid Virus Diagnostic Test - Market Report

Report Metric Details
Report Name Rapid Virus Diagnostic Test - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Hospitals
  • POCT
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Rapid Virus Diagnostic Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Rapid Virus Diagnostic Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Rapid Virus Diagnostic Test in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Rapid Virus Diagnostic Test - Market report?

Ans: The main players in the Rapid Virus Diagnostic Test - Market are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics)

What are the Application segmentation covered in the Rapid Virus Diagnostic Test - Market report?

Ans: The Applications covered in the Rapid Virus Diagnostic Test - Market report are Hospitals, POCT, Others

What are the Type segmentation covered in the Rapid Virus Diagnostic Test - Market report?

Ans: The Types covered in the Rapid Virus Diagnostic Test - Market report are Influenza, RSV, Measles, Rubella, HIV/HPV, Others

Recommended Reports

Virus Diagnostic Testing

Respiratory Diagnostics

Molecular and Lab Testing

1 Market Overview
1.1 Rapid Virus Diagnostic Test Product Introduction
1.2 Global Rapid Virus Diagnostic Test Market Size Forecast
1.3 Rapid Virus Diagnostic Test Market Trends & Drivers
1.3.1 Rapid Virus Diagnostic Test Industry Trends
1.3.2 Rapid Virus Diagnostic Test Market Drivers & Opportunity
1.3.3 Rapid Virus Diagnostic Test Market Challenges
1.3.4 Rapid Virus Diagnostic Test Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rapid Virus Diagnostic Test Players Revenue Ranking (2023)
2.2 Global Rapid Virus Diagnostic Test Revenue by Company (2019-2024)
2.3 Key Companies Rapid Virus Diagnostic Test Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rapid Virus Diagnostic Test Product Offered
2.5 Key Companies Time to Begin Mass Production of Rapid Virus Diagnostic Test
2.6 Rapid Virus Diagnostic Test Market Competitive Analysis
2.6.1 Rapid Virus Diagnostic Test Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rapid Virus Diagnostic Test Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Virus Diagnostic Test as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Influenza
3.1.2 RSV
3.1.3 Measles
3.1.4 Rubella
3.1.5 HIV/HPV
3.1.6 Others
3.2 Global Rapid Virus Diagnostic Test Sales Value by Type
3.2.1 Global Rapid Virus Diagnostic Test Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rapid Virus Diagnostic Test Sales Value, by Type (2019-2030)
3.2.3 Global Rapid Virus Diagnostic Test Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 POCT
4.1.3 Others
4.2 Global Rapid Virus Diagnostic Test Sales Value by Application
4.2.1 Global Rapid Virus Diagnostic Test Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rapid Virus Diagnostic Test Sales Value, by Application (2019-2030)
4.2.3 Global Rapid Virus Diagnostic Test Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rapid Virus Diagnostic Test Sales Value by Region
5.1.1 Global Rapid Virus Diagnostic Test Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rapid Virus Diagnostic Test Sales Value by Region (2019-2024)
5.1.3 Global Rapid Virus Diagnostic Test Sales Value by Region (2025-2030)
5.1.4 Global Rapid Virus Diagnostic Test Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rapid Virus Diagnostic Test Sales Value, 2019-2030
5.2.2 North America Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rapid Virus Diagnostic Test Sales Value, 2019-2030
5.3.2 Europe Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rapid Virus Diagnostic Test Sales Value, 2019-2030
5.4.2 Asia Pacific Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rapid Virus Diagnostic Test Sales Value, 2019-2030
5.5.2 South America Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rapid Virus Diagnostic Test Sales Value, 2019-2030
5.6.2 Middle East & Africa Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rapid Virus Diagnostic Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rapid Virus Diagnostic Test Sales Value
6.3 United States
6.3.1 United States Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.3.2 United States Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.4.2 Europe Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.5.2 China Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.6.2 Japan Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.7.2 South Korea Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.8.2 Southeast Asia Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rapid Virus Diagnostic Test Sales Value, 2019-2030
6.9.2 India Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rapid Virus Diagnostic Test Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BD
7.1.1 BD Profile
7.1.2 BD Main Business
7.1.3 BD Rapid Virus Diagnostic Test Products, Services and Solutions
7.1.4 BD Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.1.5 BD Recent Developments
7.2 Abbot (Alere)
7.2.1 Abbot (Alere) Profile
7.2.2 Abbot (Alere) Main Business
7.2.3 Abbot (Alere) Rapid Virus Diagnostic Test Products, Services and Solutions
7.2.4 Abbot (Alere) Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.2.5 Abbot (Alere) Recent Developments
7.3 Quidel
7.3.1 Quidel Profile
7.3.2 Quidel Main Business
7.3.3 Quidel Rapid Virus Diagnostic Test Products, Services and Solutions
7.3.4 Quidel Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.3.5 Roche Recent Developments
7.4 Roche
7.4.1 Roche Profile
7.4.2 Roche Main Business
7.4.3 Roche Rapid Virus Diagnostic Test Products, Services and Solutions
7.4.4 Roche Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.4.5 Roche Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Rapid Virus Diagnostic Test Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Meridian Bioscience
7.6.1 Meridian Bioscience Profile
7.6.2 Meridian Bioscience Main Business
7.6.3 Meridian Bioscience Rapid Virus Diagnostic Test Products, Services and Solutions
7.6.4 Meridian Bioscience Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.6.5 Meridian Bioscience Recent Developments
7.7 Analytik Jena
7.7.1 Analytik Jena Profile
7.7.2 Analytik Jena Main Business
7.7.3 Analytik Jena Rapid Virus Diagnostic Test Products, Services and Solutions
7.7.4 Analytik Jena Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.7.5 Analytik Jena Recent Developments
7.8 Princeton BioMeditech Corporation
7.8.1 Princeton BioMeditech Corporation Profile
7.8.2 Princeton BioMeditech Corporation Main Business
7.8.3 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Products, Services and Solutions
7.8.4 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.8.5 Princeton BioMeditech Corporation Recent Developments
7.9 BioMerieux
7.9.1 BioMerieux Profile
7.9.2 BioMerieux Main Business
7.9.3 BioMerieux Rapid Virus Diagnostic Test Products, Services and Solutions
7.9.4 BioMerieux Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.9.5 BioMerieux Recent Developments
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Profile
7.10.2 Sekisui Diagnostics Main Business
7.10.3 Sekisui Diagnostics Rapid Virus Diagnostic Test Products, Services and Solutions
7.10.4 Sekisui Diagnostics Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.10.5 Sekisui Diagnostics Recent Developments
7.11 Response Biomedical
7.11.1 Response Biomedical Profile
7.11.2 Response Biomedical Main Business
7.11.3 Response Biomedical Rapid Virus Diagnostic Test Products, Services and Solutions
7.11.4 Response Biomedical Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.11.5 Response Biomedical Recent Developments
7.12 SA Scientific
7.12.1 SA Scientific Profile
7.12.2 SA Scientific Main Business
7.12.3 SA Scientific Rapid Virus Diagnostic Test Products, Services and Solutions
7.12.4 SA Scientific Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.12.5 SA Scientific Recent Developments
7.13 DiaSorin (Focus Diagnostics)
7.13.1 DiaSorin (Focus Diagnostics) Profile
7.13.2 DiaSorin (Focus Diagnostics) Main Business
7.13.3 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Products, Services and Solutions
7.13.4 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Revenue (US$ Million) & (2019-2024)
7.13.5 DiaSorin (Focus Diagnostics) Recent Developments
8 Industry Chain Analysis
8.1 Rapid Virus Diagnostic Test Industrial Chain
8.2 Rapid Virus Diagnostic Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rapid Virus Diagnostic Test Sales Model
8.5.2 Sales Channel
8.5.3 Rapid Virus Diagnostic Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Rapid Virus Diagnostic Test Market Trends
    Table 2. Rapid Virus Diagnostic Test Market Drivers & Opportunity
    Table 3. Rapid Virus Diagnostic Test Market Challenges
    Table 4. Rapid Virus Diagnostic Test Market Restraints
    Table 5. Global Rapid Virus Diagnostic Test Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Rapid Virus Diagnostic Test Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Rapid Virus Diagnostic Test Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Rapid Virus Diagnostic Test Product Type
    Table 9. Key Companies Time to Begin Mass Production of Rapid Virus Diagnostic Test
    Table 10. Global Rapid Virus Diagnostic Test Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Virus Diagnostic Test as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Rapid Virus Diagnostic Test Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Rapid Virus Diagnostic Test Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Rapid Virus Diagnostic Test Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Rapid Virus Diagnostic Test Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Rapid Virus Diagnostic Test Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Rapid Virus Diagnostic Test Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Rapid Virus Diagnostic Test Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Rapid Virus Diagnostic Test Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Rapid Virus Diagnostic Test Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Rapid Virus Diagnostic Test Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Rapid Virus Diagnostic Test Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Rapid Virus Diagnostic Test Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Rapid Virus Diagnostic Test Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Rapid Virus Diagnostic Test Sales Value by Region (2019-2024) & (%)
    Table 27. Global Rapid Virus Diagnostic Test Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Rapid Virus Diagnostic Test Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Rapid Virus Diagnostic Test Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Rapid Virus Diagnostic Test Sales Value, (2025-2030) & (US$ Million)
    Table 31. BD Basic Information List
    Table 32. BD Description and Business Overview
    Table 33. BD Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of BD (2019-2024)
    Table 35. BD Recent Developments
    Table 36. Abbot (Alere) Basic Information List
    Table 37. Abbot (Alere) Description and Business Overview
    Table 38. Abbot (Alere) Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Abbot (Alere) (2019-2024)
    Table 40. Abbot (Alere) Recent Developments
    Table 41. Quidel Basic Information List
    Table 42. Quidel Description and Business Overview
    Table 43. Quidel Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Quidel (2019-2024)
    Table 45. Quidel Recent Developments
    Table 46. Roche Basic Information List
    Table 47. Roche Description and Business Overview
    Table 48. Roche Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Roche (2019-2024)
    Table 50. Roche Recent Developments
    Table 51. Thermo Fisher Scientific Basic Information List
    Table 52. Thermo Fisher Scientific Description and Business Overview
    Table 53. Thermo Fisher Scientific Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Thermo Fisher Scientific (2019-2024)
    Table 55. Thermo Fisher Scientific Recent Developments
    Table 56. Meridian Bioscience Basic Information List
    Table 57. Meridian Bioscience Description and Business Overview
    Table 58. Meridian Bioscience Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Meridian Bioscience (2019-2024)
    Table 60. Meridian Bioscience Recent Developments
    Table 61. Analytik Jena Basic Information List
    Table 62. Analytik Jena Description and Business Overview
    Table 63. Analytik Jena Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Analytik Jena (2019-2024)
    Table 65. Analytik Jena Recent Developments
    Table 66. Princeton BioMeditech Corporation Basic Information List
    Table 67. Princeton BioMeditech Corporation Description and Business Overview
    Table 68. Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Princeton BioMeditech Corporation (2019-2024)
    Table 70. Princeton BioMeditech Corporation Recent Developments
    Table 71. BioMerieux Basic Information List
    Table 72. BioMerieux Description and Business Overview
    Table 73. BioMerieux Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of BioMerieux (2019-2024)
    Table 75. BioMerieux Recent Developments
    Table 76. Sekisui Diagnostics Basic Information List
    Table 77. Sekisui Diagnostics Description and Business Overview
    Table 78. Sekisui Diagnostics Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Sekisui Diagnostics (2019-2024)
    Table 80. Sekisui Diagnostics Recent Developments
    Table 81. Response Biomedical Basic Information List
    Table 82. Response Biomedical Description and Business Overview
    Table 83. Response Biomedical Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of Response Biomedical (2019-2024)
    Table 85. Response Biomedical Recent Developments
    Table 86. SA Scientific Basic Information List
    Table 87. SA Scientific Description and Business Overview
    Table 88. SA Scientific Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of SA Scientific (2019-2024)
    Table 90. SA Scientific Recent Developments
    Table 91. DiaSorin (Focus Diagnostics) Basic Information List
    Table 92. DiaSorin (Focus Diagnostics) Description and Business Overview
    Table 93. DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Rapid Virus Diagnostic Test Business of DiaSorin (Focus Diagnostics) (2019-2024)
    Table 95. DiaSorin (Focus Diagnostics) Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Rapid Virus Diagnostic Test Downstream Customers
    Table 99. Rapid Virus Diagnostic Test Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Rapid Virus Diagnostic Test Product Picture
    Figure 2. Global Rapid Virus Diagnostic Test Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Rapid Virus Diagnostic Test Sales Value (2019-2030) & (US$ Million)
    Figure 4. Rapid Virus Diagnostic Test Report Years Considered
    Figure 5. Global Rapid Virus Diagnostic Test Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rapid Virus Diagnostic Test Revenue in 2023
    Figure 7. Rapid Virus Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Influenza Picture
    Figure 9. RSV Picture
    Figure 10. Measles Picture
    Figure 11. Rubella Picture
    Figure 12. HIV/HPV Picture
    Figure 13. Others Picture
    Figure 14. Global Rapid Virus Diagnostic Test Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Rapid Virus Diagnostic Test Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of POCT
    Figure 18. Product Picture of Others
    Figure 19. Global Rapid Virus Diagnostic Test Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Rapid Virus Diagnostic Test Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Rapid Virus Diagnostic Test Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Rapid Virus Diagnostic Test Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Rapid Virus Diagnostic Test Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Rapid Virus Diagnostic Test Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Rapid Virus Diagnostic Test Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Rapid Virus Diagnostic Test Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Rapid Virus Diagnostic Test Sales Value (%), (2019-2030)
    Figure 32. United States Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Rapid Virus Diagnostic Test Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Rapid Virus Diagnostic Test Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Rapid Virus Diagnostic Test Sales Value by Application (%), 2023 VS 2030
    Figure 53. Rapid Virus Diagnostic Test Industrial Chain
    Figure 54. Rapid Virus Diagnostic Test Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Data Visualization Analysis Tools Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19901
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Digital Mortgage Loan Solutions Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34K19435
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global IT Asset Inventory Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8U19855
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Computer-Aided Dispatch (CAD) Software for Public Safety Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7D19969
Mon Sep 08 00:00:00 UTC 2025

Add to Cart